subject: New Report Autoimmune Treatment Market (2009 - 2014) Published By MarketsandMarkets [print this page] Autoimmune disorders result from an overactive immune response of a body working against its own cells. Almost all autoimmune diseases are chronic and have no permanent cure. Over 300 million patients across the globe suffer from these disorders. There are around 80 autoimmune diseases; and the cause of these remains unknown. Women constitute around 70%-75% of all autoimmune patients.
This report analyzes and categorizes the overall market for autoimmune disorders into the submarkets for applications, products, services, and technology. The applications market is further classified into segments catering to systemic autoimmune diseases (that affect several organs of the body) and localized autoimmune diseases (that affect only one organ in the body). The applications market is dominated by the treatment market for rheumatoid arthritis (RA) under systemic disease segment; and by multiple sclerosis (MS) under the localized disease segment. These two diseases account for 75% of the total applications market.
The product market is classified on the basis of autoimmune drugs, diagnostic equipment, and therapeutic and monitoring equipment. Drugs constitute the largest segment of the overall autoimmune products market. Some of the major generic drugs are NSAID, DMARD, biologic DMARD and 5-ASA; some major branded drugs are Avonex, Rebif, Copaxone, and Betaseron. The drugs market, as well as the therapy and monitoring market, is growing due to the chronic nature and the wide prevalence of autoimmune diseases.
Therapy and monitoring form the largest segment of the services market. The technologies used in the treatment of rheumatoid arthritis have a much larger share in comparison to other technologies used for the treatment of psoriasis. Pharmaceutical companies are now focusing on the treatment of autoimmune diseases as these have no permanent cure. A number of government associations and non-profit organizations across the globe are also funding the R&D activities for new drugs and therapies to treat autoimmune diseases. The report provides an in-depth analysis of the applications as well as the products and services market in four geographic regions, namely North America, Europe, Asia-Pacific, and Rest of the World (ROW).
Scope of the report
Applications market for autoimmune disorders
Rheumatoid arthritis, psoriasis, lupus, multiple sclerosis, inflammatory bowel diseases, type I diabetes, thyroid amongst other diseases.
Services market for autoimmune disorders
Consultation and diagnosis, therapy and monitoring, drug development, and other services (such as pharmacokinetic services what a body does to a drug).
Products market for autoimmune disorders
Drugs, therapeutic and diagnostic equipment, and other products (such as bioinformatics).
What makes our reports unique?
We provide the longest market segmentation chain in the industry with our three-level market breakdown and our analysis of minimum 40 collectively exhaustive and mutually exclusive micro markets.
We provide 10% customization to ensure that our clients find the specific market intelligence they need.
Each report is about 150 pages, featuring 30+ market data tables, 30+ company profiles, and an analysis of 200 patents.
No single report by any other publisher provides market data for all market segments (i.e. products, services, applications, ingredients, and technology) covering the four geographies of North America, Europe, Asia Pacific, and ROW.
15 pages of high level analysis identifying opportunities, best practices, entry strategies, benchmarking strategies, market positioning, product positioning, and competitive positioning.
Key questions answered
Which are the high-growth segments and how is the market segmented in terms of applications, products, services, ingredients, technologies, stakeholders?
What are market estimates and forecasts; which markets are doing well and which are not?
Where are the gaps and opportunities; what factors are driving market growth?
Which are the key playing fields and winning-edge imperatives?
What is the competitive landscape; who are the main players in each segment; what are their strategic directives, operational strengths, key selling products, and product pipelines? Who is doing what?
Powerful Research and analysis
The analysts working with MarketsandMarkets come from renowned publishers and market research firms globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies.
